M.Dip.Tech. (Homoeopathy) / The aim of the study was to compare the effectiveness of the Homoeopathic simplex Zincum metallicum in a D6 potency with the Homoeopathic complex treatment Spascupreel in Restless leg syndrome sufferers in terms ofpatient response to treatment. It was hypothesised that the Homoeopathic simplex Zincum metallicum in a D6 potency.Both the homoeopathic simplex Zincum metallicum D6 preparation and homoeopathic complex Spascupreel preparation was found to bring about an improvement in the symptoms ofrestless leg syndrome. However Zincum metallicum D6 showed a much greater improvement that was statistically significant. and the Homoeopathic complex Spascupreel would result in a substantial improvement in all the clinical aspects ofRestless leg syndrome sufferers, and that it could be used as an alternative to "conventional" treatment in many cases. The study, conducted over a period of 3 months, was a clinical trial, in which a placebo control group was compared with two experimental groups. Convenience sampling was used to draw patients into the trial. Volunteers responded to advertisements, which had been placed in various advertising media. The persons who responded to the advertisements were requested to complete Questionnaires one and two and of those who met the criteria, which clearly indicated that they were sufferers of Restless leg syndrome, a maximum of 30 volunteers were accepted for the study. An independent party randomly divided the participants into three groups and the study was conducted over a period ofthree months. During this period 10 of the participants received placebo treatment, 10 received the Homoeopathic simplex Zincum metallicum in a D6 potency and 10 received the Homoeopathic complex Spascupreel. Being a double-blind study neither the researcher nor the participants knew what type of treatment they received until the end of the research. The participants who fell into the placebo group were given the opportunity after the study to be treated with Homoeopathic simplex or complex treatment depending on the effectiveness.

Disruption of sleep causes adverse health outcomes and poor quality of life. People with sleep disruption have higher levels than people without disrupted sleep of depression and anxiety and increased rates of cardiovascular diseases. Women have a higher incidence than men of insomnia and depression related to poor sleep. The types of complaints differ significantly between the sexes. Women are more likely than men to complain of insomnia, headache, irritability, and fatigue than the "typical" symptoms of loud snoring and breathing cessation during sleep. Hormones play an important role in sleep in women. Reproductive hormones were found to have a protective effect on sleep apnea in women of premenopausal age. Pregnancy is another period when the prevalence of sleep apnea and restless leg syndrome increases from hormonal effect. Cardiovascular mortality is high in women with obstructive sleep apnea. Continuous positive airway pressure therapy improves outcomes in most cases of obstructive sleep apnea. The epidemiology, risk factors, diagnostic criteria, and therapies for the three most common sleep disorders (insomnia, obstructive sleep apnea, and restless leg syndrome), along with effects of menopause, pregnancy, and social factors on sleep in women, are key considerations for clinicians caring for female patients across the adult life span.

Disruption of sleep causes adverse health outcomes and poor quality of life. People with sleep disruption have higher levels than people without disrupted sleep of depression and anxiety and increased rates of cardiovascular diseases. Women have a higher incidence than men of insomnia and depression related to poor sleep. The types of complaints differ significantly between the sexes. Women are more likely than men to complain of insomnia, headache, irritability, and fatigue than the "typical" symptoms of loud snoring and breathing cessation during sleep. Hormones play an important role in sleep in women. Reproductive hormones were found to have a protective effect on sleep apnea in women of premenopausal age. Pregnancy is another period when the prevalence of sleep apnea and restless leg syndrome increases from hormonal effect. Cardiovascular mortality is high in women with obstructive sleep apnea. Continuous positive airway pressure therapy improves outcomes in most cases of obstructive sleep apnea. The epidemiology, risk factors, diagnostic criteria, and therapies for the three most common sleep disorders (insomnia, obstructive sleep apnea, and restless leg syndrome), along with effects of menopause, pregnancy, and social factors on sleep in women, are key considerations for clinicians caring for female patients across the adult life span.